Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.

Lee HC, Shah JJ, Feng L, Manasanch EE, Lu R, Morphey A, Crumpton B, Patel KK, Wang ML, Alexanian R, Thomas SK, Weber DM, Orlowski RZ.

Blood Cancer J. 2019 Oct 1;9(10):80. doi: 10.1038/s41408-019-0240-6. No abstract available.

2.

Phase I/Ib study of carfilzomib and panobinostat with or without dexamethasone in patients with relapsed/refractory multiple myeloma.

Manasanch EE, Shah JJ, Lee HC, Weber DM, Thomas SK, Amini B, Olsem J, Crumpton B, Morphey A, Berkova Z, Feng L, Orlowski RZ.

Haematologica. 2019 Aug 14. pii: haematol.2019.225375. doi: 10.3324/haematol.2019.225375. [Epub ahead of print]

3.

Soft drinks and in vitro dental erosion.

Gravelle BL, Hagen TW II, Mayhew SL, Crumpton B, Sanders T, Horne V.

Gen Dent. 2015 Jul-Aug;63(4):33-8.

PMID:
26147165
4.

Effects on smear layer and debris removal with varying volumes of 17% REDTA after rotary instrumentation.

Crumpton BJ, Goodell GG, McClanahan SB.

J Endod. 2005 Jul;31(7):536-8.

PMID:
15980717
5.

Determining the nature of oral ulcerations.

Crumpton B, McGinnis JP, Krolls SO.

Dentistry. 1998 Oct;18(3):24-5; quiz 26. No abstract available.

PMID:
10613122
6.

The Bascom Palmer Eye Institute Lyme/syphilis survey.

Smith JL, Crumpton BC, Hummer J.

J Clin Neuroophthalmol. 1990 Dec;10(4):255-60.

PMID:
2150843

Supplemental Content

Loading ...
Support Center